| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178523 Novel druggable regions in set domain proteins, and methods of using the same |
| 08/02/2007 | US20070178518 Using presence of single nucleotide polymorphisms as evaluative tools in predicting skin cell proliferative disorders |
| 08/02/2007 | US20070178437 Methods and compositions for the production of high concentration alloxazine solutions |
| 08/02/2007 | US20070178176 Composition and method for promoting weight loss |
| 08/02/2007 | US20070178175 Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same |
| 08/02/2007 | US20070178164 Pharmaceutical formulations of oxcarbazepine and methods for its preparation |
| 08/02/2007 | US20070178161 Use of n-acetryl-d-glucosamine in treating and controlling non-specific inflammations caused by physical or chemical factors |
| 08/02/2007 | US20070178158 Stabilized bone graft |
| 08/02/2007 | US20070178155 Preparation for gastric buoyant sustained drug release dosage form |
| 08/02/2007 | US20070178152 Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
| 08/02/2007 | US20070178151 Spray dried pharmaceutical compositions |
| 08/02/2007 | US20070178149 Levodopa compositions |
| 08/02/2007 | US20070178141 Vitamin B12 compositions |
| 08/02/2007 | US20070178137 Local control of inflammation |
| 08/02/2007 | US20070178134 Pyridines and uses thereof |
| 08/02/2007 | US20070178121 Methods for enhancing skin treatments |
| 08/02/2007 | US20070178111 Identification and application of antibiotic synergy |
| 08/02/2007 | US20070178107 Method and means for treating solid tumors |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178104 Methods and means for treating solid tumors |
| 08/02/2007 | US20070178099 Suppression of TNFalpha and IL-12 in therapy |
| 08/02/2007 | US20070178081 Combination therapy for treating protein deficiency disorders |
| 08/02/2007 | US20070178078 Method for Modifying Gut Flora in Animals |
| 08/02/2007 | US20070178064 Use to enhance apoptosis; antiproliferative agents; IAP (inhibitor-of apoptosis) |
| 08/02/2007 | US20070178062 Treatment of presbyopia with picolinic acid and its analogs |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | US20070178051 Sterilized nanoparticulate glucocorticosteroid formulations |
| 08/02/2007 | US20070178050 Methods and systems for the delivery of corticosteroids having an increased lung depositon |
| 08/02/2007 | US20070178049 Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 08/02/2007 | US20070178048 administering an effective amount of p-menthane-3,8-diol (PMD) to destroy, inactivate, or inhibit the growth or reproduction of a virus (influenza virus, A/Sydney/5/97 virus, Urbani SARS virus and HSV-1 virus); antiseptic and antifungal agent; PMD rich extract derived from lemon eucalyptus |
| 08/02/2007 | DE102006004327A1 Chromen-4-on-Derivate Chromen-4-one derivatives |
| 08/02/2007 | DE102006003697A1 Verwendung als Arzneimittel Use as a medicament |
| 08/02/2007 | DE102006003512A1 Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen Plate-like drugs for transbukkalen application of drugs |
| 08/02/2007 | DE102006002649A1 New aza-heterocycle compounds are tyrosine kinase inhibitors useful to treat and/or prevent e.g. cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases |
| 08/02/2007 | DE10138935B4 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus Synthetic compounds from non-mucin or its conjugated with a carrier compounds monoclonal antibody prepared using them, this comprehensive antitumor agents and immunostimulants agents against human immunodeficiency virus |
| 08/02/2007 | CA2823751A1 Methods and compositions for treating feline hyperthyroidism |
| 08/02/2007 | CA2640950A1 Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same |
| 08/02/2007 | CA2640386A1 Treatment of alzheimer's disease and related conditions |
| 08/02/2007 | CA2640223A1 Methods and compositions for treating schizophrenia |
| 08/02/2007 | CA2640213A1 2-[6-(methylamino)pyridine-3-yl]-1,3-benzothiazole-6-ol for measuring an anyloid deposit |
| 08/02/2007 | CA2640159A1 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
| 08/02/2007 | CA2640141A1 Acyclic sulfamide derivatives |
| 08/02/2007 | CA2640090A1 Substituted aromatic compounds for inflammation and immune-related uses |
| 08/02/2007 | CA2640087A1 Methods and compositions for modulating the mobilization of stem cells |
| 08/02/2007 | CA2639927A1 Substituted biaryl compounds for inflammation and immune-related uses |
| 08/02/2007 | CA2639913A1 Phenyl and pyridyl compounds for inflammation and immune-related uses |
| 08/02/2007 | CA2639910A1 Thiazole and thiadiazole compounds for inflammation and immune-related uses |
| 08/02/2007 | CA2639406A1 Methods of increasing oral bioavailability of tetracyclines |
| 08/02/2007 | CA2638837A1 Lna modified phosphorothiolated oligonucleotides |
| 08/02/2007 | CA2638773A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 08/02/2007 | CA2637933A1 Indole sulfonamide modulators of progesterone receptors |
| 08/02/2007 | CA2637925A1 Levetiracetam formulations and methods for their manufacture |
| 08/02/2007 | CA2637726A1 Anti-histamine compositions and use thereof |
| 08/02/2007 | CA2637644A1 Treatment of acute respiratory distress syndrome |
| 08/02/2007 | CA2637463A1 Synergistic compositions for treating hiv |
| 08/02/2007 | CA2637447A1 A composition including a silicone-based polymer and a method of treating skin disorders using the composition |
| 08/02/2007 | CA2637375A1 Compounds for the treatment of metabolic disorders |
| 08/02/2007 | CA2637373A1 Compounds for the treatment of metabolic disorders |
| 08/02/2007 | CA2637335A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 08/02/2007 | CA2637312A1 Use of substituted 2-imidazole of imidazoline derivatives |
| 08/02/2007 | CA2637308A1 Use of 4-imidazole derivatives for cns disorders |
| 08/02/2007 | CA2637300A1 Pharmaceutical forms in film form for use in the mouth (wafers) |
| 08/02/2007 | CA2637287A1 Novel lactams |
| 08/02/2007 | CA2637275A1 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 08/02/2007 | CA2637274A1 Soft-gelatin capsule formulation |
| 08/02/2007 | CA2637261A1 Use of 2-imidazoles for the treatment of cns disorders |
| 08/02/2007 | CA2637081A1 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppressive and anti -inflammatory agents |
| 08/02/2007 | CA2636931A1 Piperazines and piperidines as mglur5 potentiators |
| 08/02/2007 | CA2636867A1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 08/02/2007 | CA2636787A1 Novel histidine derivatives |
| 08/02/2007 | CA2636757A1 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 08/02/2007 | CA2636701A1 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors |
| 08/02/2007 | CA2636696A1 Inhibitors of tyrosine kinases and uses thereof |
| 08/02/2007 | CA2636646A1 Formulations and methods for treating dry eye |
| 08/02/2007 | CA2636290A1 Compounds for the treatment of metabolic disorders |
| 08/02/2007 | CA2636043A1 Tricyclic inhibitors of 5-lipoxygenase |
| 08/02/2007 | CA2635920A1 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 08/02/2007 | CA2635760A1 Modulators of atp-binding cassette transporters |
| 08/02/2007 | CA2635439A1 Aminophthalazine derivative compounds |
| 08/02/2007 | CA2635211A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 08/02/2007 | CA2635210A1 Hydroxyalkylarylamide derivatives |
| 08/02/2007 | CA2635209A1 Fluorinated arylamide derivatives |
| 08/02/2007 | CA2635208A1 Streptococcus pneumonia having a capsular polysaccharide repeating unit (>2) glucose 1(1>3) glucose 2(1>3) rhamnose (1>3) ribitol (5>phosphate) |
| 08/02/2007 | CA2635126A1 Tetrahydropyrane antibiotics |
| 08/02/2007 | CA2635124A1 Novel pyridine derivatives |
| 08/02/2007 | CA2627692A1 Spiro imidazole derivatives as ppar modulators |
| 08/02/2007 | CA2627607A1 Fap inhibitors |
| 08/02/2007 | CA2626551A1 Azithromycin for treatment of granulomatous rosacea |
| 08/02/2007 | CA2620855A1 Wortmannin conjugates and uses thereof |
| 08/02/2007 | CA2607494A1 Nanoparticulate clopidogrel formulations |
| 08/02/2007 | CA2602922A1 Antibacterial compounds and uses thereof |
| 08/02/2007 | CA2597724A1 Cationic lipids and formulated molecular compositions containing them |
| 08/02/2007 | CA2597422A1 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
| 08/01/2007 | EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 08/01/2007 | EP1813620A1 Phosphonic acid derivative and therapeutic agent for disease in which high phosphate level in blood participates |
| 08/01/2007 | EP1813618A1 Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran |
| 08/01/2007 | EP1813616A2 Pyrazoloquinolines with immunomodulating activity |
| 08/01/2007 | EP1813613A1 Novel fused imidazole derivative |
| 08/01/2007 | EP1813612A1 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]b enzyl]thiazolidine-2,4-dione |